Reperfusion injury after liver preservation for transplantation.
about
HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312].Evaluating the Oxidative Stress in Inflammation: Role of MelatoninIcam-1 upregulation in ethanol-induced Fatty murine livers promotes injury and sinusoidal leukocyte adherence after transplantation.Ischemic preconditioning impairs liver regeneration in extended reduced-size livers.Characterization of microparticles after hepatic ischemia-reperfusion injury.Laser speckle contrast imaging for intraoperative assessment of liver microcirculation: a clinical pilot study.Role of hepatocytes and bile duct cells in preservation-reperfusion injury of liver grafts.Role of nitric oxide in inflammation.Kupffer cell-dependent TNF-alpha signaling mediates injury in the arterialized small-for-size liver transplantation in the mouse.Analysis of polyunsaturated fatty acids and the omega-6 inflammatory pathway in hepatic ischemia/re-perfusion injury.Induction of ischemic tolerance in rat liver via reduced nicotinamide adenine dinucleotide phosphate oxidase in Kupffer cells.The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injuryClinical translation of nitrite therapy for cardiovascular diseases.Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion.Decreased apoptosis in fatty livers submitted to subnormothermic machine-perfusion respect to cold storage.IL-13 activates STAT6 and inhibits liver injury induced by ischemia/reperfusionCorrelation of Histopathologic Findings of Non-Graft Threatening Preservation/Reperfusion Injury in Time-Zero Liver Needle Biopsies With Short-Term Post-transplantation Laboratory Alterations.Chemokine Receptors, CXCR1 and CXCR2, Differentially Regulate Exosome Release in Hepatocytes.Effects of methylprednisolone and its liver-targeted dextran prodrug on ischemia-reperfusion injury in a rat liver transplantation model.In vivo hypoxic preconditioning protects from warm liver ischemia-reperfusion injury through the adenosine A2B receptor.Protective effect of nitric oxide induced by ischemic preconditioning on reperfusion injury of rat liver graft.Roles of hepatocyte and myeloid CXC chemokine receptor-2 in liver recovery and regeneration after ischemia/reperfusion in mice.Role of ischaemic preconditioning in liver regeneration following major liver resection and transplantationPeroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice.Minocycline and N-methyl-4-isoleucine cyclosporin (NIM811) mitigate storage/reperfusion injury after rat liver transplantation through suppression of the mitochondrial permeability transition.Age-related decrease in proteasome expression contributes to defective nuclear factor-kappaB activation during hepatic ischemia/reperfusionAltered functions and expressions of drug transporters in liver, kidney and intestine in disorders of local and remote organs: possible role of oxidative stress in the pathogenesis.Interleukin-13 protects mouse intestine from ischemia and reperfusion injury through regulation of innate and adaptive immunity.Interferon regulatory factor-1 activates autophagy to aggravate hepatic ischemia-reperfusion injury via the P38/P62 pathway in miceTumor necrosis factor-α in liver ischemia/reperfusion injury.siRNA technology in kidney transplantation: current status and future potential.Modulation of autophagy for the treatment of liver diseases.Ursodeoxycholyl lysophosphatidylethanolamide inhibits cholestasis- and hypoxia-induced apoptosis by upregulating antiapoptosis proteins.Current status of vascularized composite tissue allotransplantation.Impact of the serum ferritin concentration in liver transplantation.The anti-inflammatory effect of erythropoietin and melatonin on renal ischemia reperfusion injury in male ratsIntravenous administration of glutathione protects parenchymal and non-parenchymal liver cells against reperfusion injury following rat liver transplantation.Epigallocatechin-3-gallate protects against hepatic ischaemia-reperfusion injury by reducing oxidative stress and apoptotic cell death.The vitamin D analogue paricalcitol attenuates hepatic ischemia/reperfusion injury through down-regulation of Toll-like receptor 4 signaling in rats.Autophagy and liver ischemia-reperfusion injury.
P2860
Q24813738-00BEE82C-39AC-4841-8792-C8FBC336A338Q26801531-60B04D4D-587E-43EA-82C6-F8AD1192BFA5Q30518813-64AC2A09-EBF5-4026-9831-F6BDB063CECBQ33212247-A8DA3EB5-97A3-4447-BA77-C0EDEB83EC5BQ33689943-79A535B1-E357-4AFE-A3E1-F9A0C0980573Q34005514-03936061-7324-4EF1-950B-96A8F3131DF5Q34249124-7DA6286A-A42E-4843-8BB8-E22333A170DCQ34418998-AEE1E627-C109-4CBC-806F-A6E1EB804A01Q34446369-FDFF61D2-82A8-459E-9FE1-6CD8F2E89975Q34480193-DFB472D4-FB60-4C29-B7F6-BF108C567B41Q35615803-B26F9F5E-6BD6-4AC8-81EA-159277706486Q35679518-C5FD508A-6781-4A09-A048-37AD0A78C124Q35686746-C98EFB1A-D422-4337-8748-9519008361C0Q35747815-4406245F-4115-4773-9DD2-8CFAFBAF04E4Q35771439-D7C5392A-4E91-4479-9B22-7D67C7CA4EE3Q35788221-FD0A24D5-0569-45EE-9CDE-0B70BA7192E7Q35941504-B2403D3E-2CE3-4EED-8D1C-41C0B40FAE03Q36110091-2AE2F154-2FDB-46AA-BFCB-E426CA4C7122Q36168619-03FDCBF8-D4A8-4CF1-9D45-C3EBD2250669Q36377291-910DB80A-FA32-479F-A8C4-473B429AA6DBQ36474609-2097D6F1-A3FC-404A-99F4-EC00B97933DDQ36518263-FA549158-BD2B-4929-B9DF-32A80F1596B9Q36728101-C74118A0-48CE-4AB0-B6D1-8BFD377AAD13Q37100292-59C447B1-770E-474A-8C23-402F55ED82BBQ37130634-2A05DF71-BE67-43D4-AED8-264D6D84ABB0Q37226065-D539E793-5F85-48E4-8A37-148B2034677EQ37556541-8FF729AD-D32F-4CE0-9699-E7D07F54CDD0Q37638328-3384799D-89E8-4264-849B-FDD8CBB5485EQ37683938-62C612B7-EA74-41DB-80A3-B13BA72AF32BQ37889969-F062AA1B-312D-4A82-8806-904921E64F0AQ38191482-AFF9F6D2-3A76-4F0B-A7FA-82894CB9B4ACQ38205866-6519CFBC-09A8-4251-9728-9B01BF7CBDD4Q38965833-F0EC38AF-7377-4D90-99B6-B2F689C5346AQ39284584-680A1591-D97B-4492-9F4D-2A468BED5B2DQ40679845-595284E4-6438-4B26-BA12-A0BBADD6E92CQ41859941-AD111A79-37CF-42D0-9766-FFA4F052AA55Q41891695-AE92A02D-08AB-4B8C-979E-D6934AC5732CQ41949001-B8D78F6C-918F-4A71-876F-9D6F1463AED8Q41956279-2EBCF4E6-1FCE-4776-B512-1CE766EF0985Q42094967-C07793B6-1EE3-4293-9FBE-8F00FCF5F81D
P2860
Reperfusion injury after liver preservation for transplantation.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Reperfusion injury after liver preservation for transplantation.
@ast
Reperfusion injury after liver preservation for transplantation.
@en
Reperfusion injury after liver preservation for transplantation.
@nl
type
label
Reperfusion injury after liver preservation for transplantation.
@ast
Reperfusion injury after liver preservation for transplantation.
@en
Reperfusion injury after liver preservation for transplantation.
@nl
prefLabel
Reperfusion injury after liver preservation for transplantation.
@ast
Reperfusion injury after liver preservation for transplantation.
@en
Reperfusion injury after liver preservation for transplantation.
@nl
P1476
Reperfusion injury after liver preservation for transplantation.
@en
P2093
Lemasters JJ
Thurman RG
P304
P356
10.1146/ANNUREV.PHARMTOX.37.1.327
P577
1997-01-01T00:00:00Z